EMX2OS and metastatic malignant neoplasm in the lymph nodes: EMX2OS downregulation was significantly associated with unfavorable clinicopathological features such as higher histological grade, larger tumor size, lymph node metastasis, distant metastasis, and advanced AJCC stage.